Myomo outlines revised 2025 revenue growth target of 23%-29% as lead quality and pipeline conversion shift
Source: SeekingAlpha
2025-08-11 18:57:38 ET
More on Myomo
- Myomo, Inc. (MYO) Q2 2025 Earnings Conference Call Transcript
- Seeking Alpha’s Quant Rating on Myomo
- Historical earnings data for Myomo
- Financial information for Myomo
Read the full article on Seeking Alpha
For further details see:
Myomo outlines revised 2025 revenue growth target of 23%-29% as lead quality and pipeline conversion shift
Myomo Inc.
NASDAQ: MYO
MYO Trading
2.58% G/L:
$0.7105 Last:
198,291 Volume:
$0.7258 Open:
MYO Latest News
March 09, 2026 04:06:00 pm
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
March 09, 2026 04:05:00 pm
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation
MYO Stock Data
$31,609,375
36,594,462
4.42%
23
N/A
Medical Equipment & Supplies
Healthcare
US
Burlington
